Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
Saved in:
| Title: | Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate. |
|---|---|
| Authors: | Fein, Luis1 (AUTHOR) luisfein@institutodeoncologia.com, Lazaretti, Nicolas2 (AUTHOR), Chuken, Yamil López3 (AUTHOR), Benfield, J. Rogelio González Ramírez4 (AUTHOR), Mano, Max S.5 (AUTHOR), Lobaton, Jose6 (AUTHOR), Korbenfeld, Ernesto7 (AUTHOR), Damian, Fernanda8 (AUTHOR), Lu, Dongrui R.9 (AUTHOR), Mori, Ave10 (AUTHOR), Patyna, Shem J.9 (AUTHOR), Franco, Sandra11 (AUTHOR) |
| Source: | Clinical Drug Investigation. Sep2023, Vol. 43 Issue 9, p699-706. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11732563 |
|---|---|
| DOI: | 10.1007/s40261-023-01294-3 |
